Solara Active Pharma Sciences Ltd (SOLARA)
₹620.3▲2.72%
🔔 Earnings Alert
Solara Active Pharma Sciences reports Q1 net loss of ₹134.6m, but revenue expected to grow by 13% p.a. for next 3 years, shares up 6.8% from a week ago
Analyst Rating
based on 1 analysts
0.00%
Buy
0.00%
Hold
100.00%
Sell
Based on 1 analysts offering long term price targets for Solara Active Pharma Sciences Ltd. An average target of ₹361
Source: S&P Global Market Intelligence
Solara Active Pharma Sciences Ltd Share analysis
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹590.7₹63152 Week's Low
52 Week's High
₹263.55₹639.7
| Returns % | |
| 1 Month Return | + 33.28 % |
| 3 Month Return | + 9.48 % |
| 1 Year Return | + 53.53 % |
| Market Stats | |
| Previous Close | ₹603.90 |
| Open | ₹610.10 |
| Volume | 1.42L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,174.36Cr |
Key Statistics
| P/E Ratio | -4.2 |
| PEG Ratio | 0.03 |
| Market Cap | ₹2,174.36 Cr |
| P/B Ratio | 0.79 |
| EPS | 21.2436522492466 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| ₹2,174.36 Cr | 12.82% | 0.71 | -₹23 Cr | ₹1,443 Cr | |
 | NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
| NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
 | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
| NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Company Information
Share Price: ₹620.30 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹2,174.36Cr as of today
Revenue: ₹363.49Cr as on June 2024 (Q2 24)
Net Profit: ₹-13.46Cr as on June 2024 (Q2 24)
Listing date: 27 Jun, 2018
Chairperson Name: Aditya Puri
| Organisation | Solara Active Pharma Sciences Ltd |
| Headquarters | Chennai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
What's happening today
Today's Timeline - Invalid Date
06:45 AM
-Solara Active Pharma Sciences faces challenges with net loss of INR 134.6 million, but shows potential for recovery as earnings are expected to grow significantly.
07:00 AM
-Solara Active Pharma Sciences reports Q1 2025 net loss of INR 134.6m, an improvement from last year. Revenue projected to grow by 13% p.a., shares up 6.8% in a week.
Key events for Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences Shows Potential for Recovery - 24 Jul, 2024
Despite facing challenges and reporting a net loss in Q1 2025, Solara Active Pharma Sciences is expected to recover with significant earnings growth projections and strategic expansions. The company's revenue is forecasted to grow by 13% p.a., outpacing the Indian market forecast of 9.9%. Shares have also seen a positive trend, increasing by 6.8% in a week.
Solara Active Pharma Sciences Reports 3.17% YoY Growth in Net Sales - 23 Jul, 2024
Solara Active Pharma Sciences reported a 3.17% YoY growth in net sales for June 2024, with quarterly net loss at Rs. 12.32 crore and EBITDA at Rs. 43.62 crore. The stock has given returns of 49.41% over the last 6 months and 46.22% over the last 12 months.
Solara Active Pharma Sciences projected to breakeven by 2025 - 05 Jul, 2024
Analysts anticipate Solara Active Pharma Sciences to generate positive profits of ₹417m in 2025, projecting the company to breakeven around 12 months from now or less. However, the company will have to grow at an optimistic rate of 141% year-on-year to reach this consensus forecast.
TPG Sells 20 Lakh Shares of Solara Active Pharma Sciences for Rs 99 Crore - 28 Jun, 2024
Private equity firm TPG has sold 20 lakh shares of Solara Active Pharma Sciences for Rs 99 crore through an open market transaction. The shares were acquired by Mumbai-based NBFC company Authum Investment & Infrastructure at the same price. On Friday, shares of Solara Active Pharma Sciences surged 9.99% to close at Rs 544.90 apiece on the NSE.
Insights on Solara Active Pharma Sciences Ltd
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, -275.34 Cr → -13.46 Cr (in ₹), with an average increase of 902.4% per quarter
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 30.49% to 37.27% in Jun 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 249.18 Cr → 364.05 Cr (in ₹), with an average increase of 17.3% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, SOLARA stock has moved up by 9.2%
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 192.7%
- NO EFFECT
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 33.6%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 50.74% to 45.90% in Jun 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 1.71% to 1.28% in Jun 2024 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 15.80% to 14.00% in Jun 2024 quarter
Company Financials
| Q'2 24 | Q/Q Change | |
|---|---|---|
Revenue | ₹363.49Cr | ↑21.39% |
Net Income | -₹13.46Cr | ↓94.73% |
Net Profit Margin | -3.70% | ↓95.66% |
| 2023 | Y/Y Change | |
|---|---|---|
Revenue | ₹1,443.81Cr | ↑13.83% |
Net Income | -₹22.25Cr | ↓61.83% |
Net Profit Margin | -1.54% | ↓66.52% |
| 2023 | Y/Y Change | |
|---|---|---|
Total Assets | ₹2,978.26Cr | ↓1.33% |
Total Liabilities | ₹1,475.13Cr | ↓1.08% |
| 2023 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | ₹156.17Cr | ↓164.59% |
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 37.27% | 22.24 | |
| Foreign Institutions | 14% | ||
| Mutual Funds | 1.28% | ||
| Retail Investors | 45.9% | ||
| Others | 1.55% | 22.38 |
Key Indicators
Solara Active Pharma Sciences Ltd Valuation
Solara Active Pharma Sciences Ltd in the last 5 years
Lowest (-1080.15x)
January 14, 2022
Today (-4.20x)
July 23, 2024
Industry (56.07x)
July 23, 2024
Highest (31.03x)
October 1, 2021
Earnings and Dividends
Solara Active Pharma Sciences Ltd Earnings Results
Solara Active Pharma Sciences Ltd’s net profit jumped 31.15% since last year same period to ₹-13.46Cr in the Q1 2024-2025. On a quarterly growth basis, Solara Active Pharma Sciences Ltd has generated 94.73% jump in its net profits since last 3-months.
Read More about Earnings ResultsSolara Active Pharma Sciences Ltd Dividends May,2021
In the quarter ending March 2021, Solara Active Pharma Sciences Ltd has declared dividend of ₹3 - translating a dividend yield of 1.49%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Solara Active Pharma Sciences Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Solara Active Pharma Sciences Ltd shares.
Solara Active Pharma Sciences Ltd (SOLARA) share price today is ₹620.3
Solara Active Pharma Sciences Ltd is listed on NSE
Solara Active Pharma Sciences Ltd is listed on BSE
- Today’s highest price of Solara Active Pharma Sciences Ltd is ₹631.
- Today’s lowest price of Solara Active Pharma Sciences Ltd is ₹590.7.
PE Ratio of Solara Active Pharma Sciences Ltd is -4.2
PE ratio = Solara Active Pharma Sciences Ltd Market price per share / Solara Active Pharma Sciences Ltd Earnings per share
Today’s traded volume of Solara Active Pharma Sciences Ltd(SOLARA) is 1.42L.
Today’s market capitalisation of Solara Active Pharma Sciences Ltd(SOLARA) is ₹2174.36Cr.
| Solara Active Pharma Sciences Ltd(SOLARA | Price |
|---|---|
52 Week High | ₹639.7 |
52 Week Low | ₹263.55 |
Solara Active Pharma Sciences Ltd(SOLARA) share price is ₹620.3. It is down -3.03% from its 52 Week High price of ₹639.7
Solara Active Pharma Sciences Ltd(SOLARA) share price is ₹620.3. It is up 135.36% from its 52 Week Low price of ₹263.55
| Solara Active Pharma Sciences Ltd(SOLARA | Returns |
|---|---|
1 Day Returns | 16.4% |
1 Month Returns | 33.28% |
3 Month Returns | 9.48% |
1 Year Returns | 53.53% |